| Literature DB >> 35663339 |
Mahsa Janmohammadi1, Zahra Nazemi1, Amin Orash Mahmoud Salehi1, Amir Seyfoori2, Johnson V John3, Mohammad Sadegh Nourbakhsh4, Mohsen Akbari2,3,5.
Abstract
Natural bone constitutes a complex and organized structure of organic and inorganic components with limited ability to regenerate and restore injured tissues, especially in large bone defects. To improve the reconstruction of the damaged bones, tissue engineering has been introduced as a promising alternative approach to the conventional therapeutic methods including surgical interventions using allograft and autograft implants. Bioengineered composite scaffolds consisting of multifunctional biomaterials in combination with the cells and bioactive therapeutic agents have great promise for bone repair and regeneration. Cellulose and its derivatives are renewable and biodegradable natural polymers that have shown promising potential in bone tissue engineering applications. Cellulose-based scaffolds possess numerous advantages attributed to their excellent properties of non-toxicity, biocompatibility, biodegradability, availability through renewable resources, and the low cost of preparation and processing. Furthermore, cellulose and its derivatives have been extensively used for delivering growth factors and antibiotics directly to the site of the impaired bone tissue to promote tissue repair. This review focuses on the various classifications of cellulose-based composite scaffolds utilized in localized bone drug delivery systems and bone regeneration, including cellulose-organic composites, cellulose-inorganic composites, cellulose-organic/inorganic composites. We will also highlight the physicochemical, mechanical, and biological properties of the different cellulose-based scaffolds for bone tissue engineering applications.Entities:
Keywords: Bone tissue engineering; Cellulose; Cellulose derivatives; Drug delivery system
Year: 2022 PMID: 35663339 PMCID: PMC9142858 DOI: 10.1016/j.bioactmat.2022.05.018
Source DB: PubMed Journal: Bioact Mater ISSN: 2452-199X
Fig. 1Chemical formulation of cellulose and its derivatives [27].
Fig. 2A. Schematic illustration for PLA/RC scaffold fabrication [51]. B. Calcium and phosphate nucleation by biomimetic method in PLA/RC scaffold [51]. C. 3D printed T-CNF/SA hydrogels in different forms [65]. D. 3D printed cell-encapsulated bio-ink was spontaneously gelled at 37 °C [71].
Cellulose- organic composite scaffolds in bone tissue engineering.
| Composite | Fabrication method | Pore size (μm) | Porosity (%) | Mechanical properties | Type of study | Key biological results | Ref |
|---|---|---|---|---|---|---|---|
| BC-PHB | Salt leaching technique | 5–50 | ___ | Tensile Strength (MPa): 15 ± 1.0 | In vitro, In vivo (critical size calvaria defect in mice) | Increased proliferation of 3T3-L1 preadipocytes, | [ |
| CA-PULL | Electrospinning | 20–100 | (41.98 ± 10.56)- (67.64 ± 4.89) | Young's modulus (MPa): (0.43 ± 0.01) to (1.68 ± 0.09) | In vitro | Enhanced adhesion, proliferation and differentiation of human osteogenic sarcoma cell line, promoted ALP activity | [ |
| CA-COL | Oil-in water solvent-evaporation technique | 185.4 ± 8.6 | 33.9 ± 5.2 | Compressive modulus (MPa): 266-(75 ± 33)-22 (Dry scaffold), 130-(53 ± 13)-97 (Wet scaffold) | In vitro | Increased adhesion and proliferation of human osteoblast cells | [ |
| PLA-RC | Electrospinning and Freeze-drying | Minor pores: smaller than 20. | Around 96 | Young's modulus (kPa): 16.5 to 54.9 | In vitro | Increased biomineralization and bone-like apatite formation | [ |
| Na-CMC-CS- CQ | Freeze-drying | 148–239 | ___ | Compression | In vitro | Enhanced adhesion, proliferation, and mineralization of osteoblasts, increased osteogenic activity and ALP activity | [ |
| HEC-PVA | Electrospinning | (9.55 ± 0.17)- (5.98 ± 0.5) | ___ | Tensile | In vitro | Increased attachment and proliferation of human osteosarcoma cells | [ |
| HEC-PVA-CNC | Freeze-drying | 33.4-∼54.1 | 77 | ___ | In vitro | Increased adhesion and proliferation of human fetal osteoblast cells | [ |
| TEMPO-oxidized | Freeze-drying | 8–150 | 71.4 ± 1.4 | ___ | In vitro | Increased attachment, spreading and osteogenic differentiation of hBMSCs, enhanced RUNX2 and SPP1 expression | [ |
| CNC-PLLA | Selective laser sintering | 450–600 | ___ | Tensile strength (MPa): 7.93 ± 0.31 | In vitro | Enhanced adhesion, proliferation and differentiation of MG-63 cells, increased ALP activity | [ |
| Cellulose-CNCs-BMP-2 | Electrospinning | 272.4 ± 31.64 nm | 77 | ___ | In vitro, In vivo (cranial bone in rabbit) | Increased osteogenic differentiation of BMSCs, enhanced ALP activity and calcium content, induced | [ |
| BNC -SA-CS-GEL | Freeze-drying and Layer-by-layer assembly | 30–300 | 77.4 | compressive strengths (MPa): 0.27 | In vitro | Increased attachment, proliferation and differentiation of MC3T3 -E1 cells, enhanced ALP activity | [ |
| CNW-PU | Solvent casting/particulate leaching | 20–150 | 82 | Tensile strength (kPa): 112 | In vitro | Promoted proliferation, adhesion, and osteogenic differentiation of hMSCs, increased ALP activity and calcium content | [ |
| CNWs-PU-PHEMA | Solvent casting/particulate leaching | 20–150 | 85 | Tensile elasticity moduli (kPa): | In vitro | Enhanced osteogenic differentiation of hMSCs and bone mineralization | [ |
| MCC-PCL | 3D Printing | 450–500 | 57 ± 2 | Compressive modulus (MPa): 7 | In vitro | Increased proliferation of sheep bone marrow cells | [ |
Fig. 3A. Illustration of the fabricating regenerated cellulose fibers containing HAp and Ag NPs [133]. B. Schematic of creation of 3D carbon fiber reinforced CMC-HAp ternary composite [142].
Cellulose-inorganic composite scaffolds in bone tissue engineering.
| Composite | Fabrication method | Pore size (μm) | Porosity (%) | Mechanical properties | Type of study | Key biological results | Ref |
|---|---|---|---|---|---|---|---|
| BC-HAp | Ultrasonic radiation | _ | 81.1 | Compressive strength (MPa): 9.87 | In vitro | Enhanced viability and proliferation of osteoblast cells | [ |
| BC-HAp | Laser patterning technique, then modified using periodate oxidation | 300 | _ | Tensile strength (MPa): 0.16 | In vitro | Induced attachment and proliferation of osteoblast cells | [ |
| TiO2-cellulose-HAp | Freeze-drying method | 70–130 | 87 | Compressive strength (MPa): 4.1 | In vitro | Increased attachment, viability and proliferation of fibroblast cells | [ |
| CMC-HAp-Gel | One-pot method | 2.5–900 | 80 | Compressive strength (MPa): 11.8 ± 1.5 | In vitro | Enhanced osteogenic activity | [ |
| CMC-HAp-PVA | Biomineralization process | 1–10 | 11–80 | Compressive strength (MPa): 1.74 to 12 | In vitro | Improved migration and proliferation of bone marrow-mesenchymal stem cells | [ |
| CNW-45S5 BG | Foam replication | 200–550 | 93 | Compressive strength (MPa): 0.06 ± 0.01 | In vitro | No negative effect on bioactivity and cytocompatibility of MG-63 cells | [ |
| CNC-HAp-PEG- PMVEMA | Freeze-casting | _ | 91 | Compression strength (MPa): 41.8 | In vitro | Improved bovine serum albumin protein stabilization and reduced the rate of inactivation | [ |
Fig. 4A. Schematic of preparation process of the BC-GEL/HAp hydrogel [158]. B. Schematic of stress dissipating of the BC-GEL/HAp composite under external load [158]. C. Schematic of the formation mechanism of Col-CMC/HAp composites [176].
Fig. 5A. Preparation of PLA-EC/HAp porous scaffolds for bone grafting [187]. B. Bone grafting of PLA-EC/HAp porous scaffold [187]. C. Schematic of the TEMPO-oxidation of BC and the colloidal dispersion of HAp NPs. (HAp NPs/TOBC solutions with weight ratios of 1:1) [203].
Cellulose-organic/inorganic composite scaffolds in bone tissue engineering.
| Composite | Fabrication method | Pore size (μm) | Porosity (%) | Mechanical properties | Type of study | Key biological results | Ref |
|---|---|---|---|---|---|---|---|
| BC-GEL/BHAp | Freeze-drying | 45–210 | 68.49–80.94 | Young modulus (MPa): 9.61 to 11.33 | In vitro | Increased attachment, proliferation and ALP activity of Saos-2 cell line | [ |
| BC-GEL/HAp | Freeze-drying | 0.2–0.5 | ___ | Young modulus (MPa): 177 | In vitro | Increased adhesion, proliferation and differentiation of MSCs | [ |
| PAA-g-Cellulose/HAp | Freeze-drying | 72–125 | 85.7 | Elastic modulus (GPa): (0.11 ± 0.01) to (0.89 ± 0.01) | In vitro | Desirable viability for human fibroblast gum cells | [ |
| BC-PVA/hBN | 3D print | 265.6–290.1 | ___ | Tensile Strength (MPa): (0.05 ± 0.05) to (0.127 ± 0.05) | In vitro | Increased viability and adhesion of human osteoblast cells | [ |
| CA-GEL/B2O3-BG | Combined method: cold press molding-porogen leaching | ___ | 58.9 | Compressive strength (MPa): 0.82 | In vitro | Increased ALP activity and intracellular calcium in human dental pulp stem cells | [ |
| CA-PCL/Ca | Electrospinning/gas foaming | ___ | (52.4 ± 3.1)- (75.4 ± 3.8) | Tensile strength (MPa): 4.0 to 5.0 | In vitro | Increased cellular infiltration, mineralization and osteogenesis of MC3T3-E1 cells | [ |
| CMC-CS/Ag-CNW | Freeze-drying | 150–500 | 80–90 | Compressive strength (MPa): 0.35 to 3.95 | In vitro | Increased adhesion and proliferation of MG63 cells, sufficient mineralization, excellent antimicrobial activity | [ |
| CMC-CS/diatomite or POSS or SiHAp | Freeze-drying | 190–307 | 61–70 | Compressive strength (kPa): 179.3 to 254.3 | In vitro | Desirable viability for MG-63 & SW1353 cells, promoted osteogenic differentiation of MG-63 cells, increased ALP activity | [ |
| CMC-CS/CaP | Freeze-drying | 35–250 | 61–75 | Compressive strength (kPa): 150 | In vitro | Increased attachment, proliferation and mineralization of MG63 cells | [ |
| CMC-COL/HAp | Biomimetic template | 100–300 | (71 ± 4)-(75 ± 4) | Compressive strength (MPa): 3.17 to 7.06 | In vitro | Desirable viability of wild-type mouse embryonic fibroblasts cells | [ |
| CMC-CS/(Zn-Mn HAp) | Electrospinning | ___ | 98 | Tensile Strength (MPa): 65.86 ± 1.81 | In vitro | Increased antimicrobial activity, hemocompatibility and human osteoblast cell viability | [ |
| HPMC-CS/BG-ZnO | Freeze-drying | 90.5–132 | ___ | Compressive strength (MPa): 0.2869 to 0.4518 | In vitro | Increased proliferation and differentiation of MC3T3-E1 cells, good antibacterial activity | [ |
| HPMC-CS/HAp | Freeze-drying | 41–273 | 0.53–0.66 | Compressive strength (MPa): (0.223 ± 0.018) to (0.324 ± 0.046) | In vitro | Increased proliferation and differentiation of MC3T3-E1 cells | [ |
| EC-PLA/HAp | Combined method: solvent casting, particulate leaching, compression molding | 150–250 | 74.09–89.54 | Compressive modulus (MPa): (10.38 ± 2.38) to (35.21 ± 3.17) | ___ | ___ | [ |
| EC-g-PCL-SA/HAp | Combined method: electrospinning and freeze drying | (160.4 ± 57.14)-(207.05 ± 83.26) | 68.05–84.15 | Compressive strength (MPa): (0.24 ± 0.25) to (0.43 ± 0.12) | In vitro | Increased proliferation and differentiation of human dental pulp stem cells, upregulation of osteogenic genes (BGLAP, Runx2, BMP2) | [ |
| HEC-SA/HAp | Freeze-drying | ___ | (66.7 ± 3.2)-(87 ± 5.1) | Compressive Strength (MPa): (18.56 ± 0.76) to (23.96 ± 0.82) | In vitro | Increased protein adsorption, viability, and proliferation of MSCs | [ |
| GEL-CNC/BG | Combined method: in situ composite and freeze drying | 120–320 | 67–78 | Compressive strength (MPa): (1.57 ± 0.25) to (3.61 ± 0.65) | In vitro | Increased adhesion, growth and proliferation of L929 fibroblasts cells | [ |
| CNC-SF/HAp | Freeze-drying | 110 ± 7.3 | 90 ± 6.2 | Compressive stress (kPa): 200.7 ± 15.3 | In vitro, In vivo (calvarial defect in rat) | Increased viability and ALP activity of MC3T3-E1 cells, increased bone mineral density in injured animals | [ |
| CMC-SF/CNC/Sr-HAp | Freeze-drying | 64.22 ± 4.93 | 82.03 ± 1.45 | Compressive strength (KPa): 77.20 ± 4.52 | In vitro | Enhanced protein adsorption, ALP activity and osteogenic gene expression | [ |
| CS-SA/CNC | Freeze-drying | 103.16–230 | 93.6 | ___ | In vitro | Desirable viability of MG-63 cells | [ |
| Alg-XG/CNC-HNT | Freeze-drying | ___ | (88.5 ± 0.64)- (91.7 ± 0.81) | Compressive strength (kPa): (91.1 ± 1.2) to (114.4 ± 0.6) | In vitro | Desirable viability of MC3T3-E1 cells | [ |
| CMC-CS/HA | Freeze-drying | 92.10–136.00 | 49.77 | Compressive strength (MPa): 3.89 | ___ | ___ | [ |
| BC-GEL-PCL/HA | 3D print | 314.14 ± 23.2 | ___ | Tensile Strength (MPa): (1.08 ± 0.34) to (1.58 ± 0.19) | In vitro | Increased viability of human osteoblast cells | [ |
| CNC-PVA/HA | Freeze-drying | (180 ± 129)- (280 ± 124) | (87 ± 0.8)- (90 ± 0.2) | Compressive strength (MPa): 1.39 to 2.09 | ___ | ___ | [ |
| CNF-PCL/HA | Extrusion | ___ | 50.5 | Compressive modulus (MPa): 70.88 ± 8.60 | In vitro | Desirable cell viability | [ |
| MC-SF/HA | Electrospinning | ___ | (66.24 ± 0.17)– (90.11 ± 0.12) | Tensile strength (MPa): 25.39 to 102.93 | In vitro | High hemocompatibility, antimicrobial effect, increased proliferation, and ALP activity of human osteoblast cell line | [ |
Fig. 6A. Schematic of different drug delivery systems based on cellulose for bone tissue engineering. B. The ALP activity of BC-BMP-2 scaffolds after implantation (BMP-2 at 225 mg/ml for L-BMP-2/BC, and BMP-2 at 450 mg/ml for H-BMP-2/BC) [214]. C. Cumulative release of ceftazidime from EC microspheres and HAp/PU scaffolds (microspheres/scaffold-L and microspheres/scaffold-H refers to EC microspheres incorporated HAp/PU scaffolds containing 100 μg and 200 μg ceftazidime, respectively) [223].